Invention Grant
- Patent Title: Subcutaneous outpatient management
-
Application No.: US16124026Application Date: 2018-09-06
-
Publication No.: US10403397B2Publication Date: 2019-09-03
- Inventor: Robert C. Booth , Harry Hebblewhite
- Applicant: Aseko, Inc.
- Applicant Address: US SC Greenville
- Assignee: Aseko, Inc.
- Current Assignee: Aseko, Inc.
- Current Assignee Address: US SC Greenville
- Agency: Honigman LLP
- Main IPC: G01N33/48
- IPC: G01N33/48 ; G16H20/17 ; G06F19/00 ; A61M5/172 ; A61B5/00 ; A61B5/145 ; G16H10/60 ; G16H10/40 ; G16H40/67 ; G16H20/60 ; G16H50/20

Abstract:
A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.
Public/Granted literature
- US20190019577A1 Subcutaneous Outpatient Management Public/Granted day:2019-01-17
Information query